Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Menstrual blood could offer non-invasive alternative for vitamin testing, new study by theblood finds. Seen Health launches with $22M to modernize senior care through PACE program. Felloraises $10.4M to…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
Bone Health Technologies (BHT) has announced that pre-orders are now open for Osteoboost, the first FDA-cleared prescription non-drug treatment for postmenopausal women with osteopenia. The device is expected to begin shipping in the next 60-90 days. The prescription wearable device, worn around the waist, delivers targeted vibration therapy to the hips and spine – areas most susceptible to osteoporotic fractures. According to…
A new fertility treatment is showing encouraging results for couples struggling to conceive. Femasys has published results from its clinical trial of FemaSeed, a new approach to artificial insemination, in the Journal of Gynecology & Reproductive Medicine. “We are grateful for the renowned investigators from leading academic medical centers and private practices that participated in this landmark trial,” stated Kathy Lee-Sepsick, CEO…
Fello, a new peer support platform addressing the loneliness epidemic, has launched with $10.4 million in funding, including seed investments from Glen Tullman’s 62Ventures, The Capital Factory Fellowship Fund, Katalyst Capital, and Offline Ventures. The platform connects individuals seeking guidance with “Fellos” who have relevant lived experience in areas including substance use, parenting, and relationships. Led by CEO and co-founder Alyssa Pollack,…
Movano Health has received FDA 510(k) clearance for the pulse oximeter in its EvieMED Ring. The company states this clearance unlocks potential applications in clinical trials, post-clinical trial management, and remote patient monitoring for healthcare providers and payors. “We launched the Evie Ring in the consumer wearable market, but our broader goal has always been to provide a clinical-grade device for B2B…
INITIATE Ventures has announced the close of a $45 million debut venture capital fund and affiliated company creation platform. The firm focuses on building and investing in companies at the intersection of healthcare, life sciences, and technology. The firm is led by General Partners Jessica Owens and Iana Dimkova, both experienced founders and investors. Owens previously co-founded GRAIL, which Illumina, Inc. acquired…
PatientsLikeMe (PLM) has launched Ella, an AI-powered health assistant developed in partnership with Ema to support women’s health and wellness. The new tool provides personalized, evidence-based guidance throughout various life stages by combining knowledge from trusted sources like the CDC and WHO with PLM’s patient-reported data and community insights. Ella is designed to make complex medical information accessible and understandable for women…
